InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by MILESON GLENNA, Chief Financial Officer. Director active across 1 company, notably Athira Pharma, Inc.. Cumulatively, 7 reports have been logged. History available since 18 May 2021. The latest transaction was disclosed on 18 November 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
763 shares@ US$2.742.0% of flowCommon StockSEC:0001209191-22-063009:0
1,721 shares@ US$7.0611.8% of flowCommon StockSEC:0001209191-22-039342:0
3,000 shares@ US$10.6429.9% of flowCommon StockSEC:0001209191-22-024219:0
931 shares@ US$12.5110.3% of flowCommon StockSEC:0001209191-22-002218
931 shares@ US$12.5110.5% of flowCommon StockSEC:0001209191-22-002218:0
1,554 shares@ US$14.4518.7% of flowCommon StockSEC:0001209191-21-039627:0
1,554 shares@ US$14.4518.3% of flowCommon StockSEC:0001209191-21-039627
7 of 7 declarations
About MILESON GLENNA
Glenna Mileson is the Chief Financial Officer at Athira Pharma, Inc. She is responsible for the company's financial management, including budgeting and financial strategy. Her role is crucial in ensuring the financial health of the company and supporting its growth in the pharmaceutical sector.
